Tom Dugan

Tom Dugan is a seasoned executive with extensive experience in the medical device and healthcare industries, currently serving as Chairman of the Board of Directors at BioStem Technologies since December 2023. As a Partner at 360 Life Sciences Advisors, LLC since 2018, Tom Dugan focuses on strategic and operational assessments for acquisitions and investments, as well as business transformation for enhanced performance. Previous roles include President of Integrum AB in the U.S. from 2021 to 2023, where Tom Dugan oversaw the OPRA™ Implant System, along with significant positions such as CEO at Amniox Medical, President at SURGIQUEST during its acquisition by CONMED, and leadership roles at Smith & Nephew, SonoSite, and Covidien. Tom Dugan's career highlights a strong track record of driving growth and innovation within the medical sector.